Beijing Biostar Pharmaceuticals Co., Ltd. (HKG: 2563)
Hong Kong
· Delayed Price · Currency is HKD 16.30
+0.14 (0.87%)
Jan 6, 2025, 4:08 PM HKT
Beijing Biostar Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -189.64 | -189.64 | -160.51 | -278.14 | -65.25 | -55.92 |
| Depreciation & Amortization | 10.56 | 10.56 | 10.46 | 8.65 | 7.06 | 6.67 |
| Other Amortization | 0.06 | 0.06 | 0.04 | 0.03 | 0.02 | 0.01 |
| Asset Writedown & Restructuring Costs | - | - | - | 0.08 | - | - |
| Loss (Gain) From Sale of Investments | -9.1 | -9.1 | -10.85 | -22.39 | -7.36 | -9.04 |
| Stock-Based Compensation | 44.4 | 44.4 | 80.74 | - | - | - |
| Provision & Write-off of Bad Debts | -1.28 | -1.28 | 1.21 | 0.38 | -0.06 | 0.03 |
| Other Operating Activities | -15.51 | -15.51 | -22.38 | 245.59 | 19.66 | 1.39 |
| Change in Accounts Receivable | 25.22 | 25.22 | -6.9 | -20.92 | -3.5 | -2.14 |
| Change in Inventory | 3.07 | 3.07 | -8.44 | -16.99 | -3.18 | -1.8 |
| Change in Accounts Payable | 3.39 | 3.39 | 28.23 | 6.24 | -3.59 | 9.25 |
| Change in Unearned Revenue | -0.71 | -0.71 | -1.53 | -1.3 | -2.94 | -4.02 |
| Change in Other Net Operating Assets | -19.79 | -19.79 | 10.5 | - | - | - |
| Operating Cash Flow | -149.33 | -149.33 | -79.44 | -78.77 | -59.14 | -55.57 |
| Capital Expenditures | -27.84 | -27.84 | -31.86 | -11.06 | -4.81 | -11.11 |
| Sale (Purchase) of Intangibles | - | - | -0.82 | - | - | - |
| Investment in Securities | 157.67 | 157.67 | -114.11 | 121.93 | -435.53 | 60.1 |
| Other Investing Activities | - | - | - | 17.57 | 19.77 | 6.44 |
| Investing Cash Flow | 129.83 | 129.83 | -146.79 | 128.44 | -420.58 | 55.44 |
| Short-Term Debt Issued | - | - | 0.07 | - | - | - |
| Total Debt Issued | - | - | 0.07 | - | - | - |
| Short-Term Debt Repaid | -0.07 | -0.07 | - | - | - | - |
| Long-Term Debt Repaid | -1.01 | -1.01 | -1.13 | -1.08 | - | - |
| Total Debt Repaid | -1.07 | -1.07 | -1.13 | -1.08 | - | - |
| Net Debt Issued (Repaid) | -1.07 | -1.07 | -1.06 | -1.08 | - | - |
| Issuance of Common Stock | - | - | - | 0.27 | 710.12 | - |
| Other Financing Activities | -0.06 | -0.06 | 4.59 | - | -7.95 | - |
| Financing Cash Flow | -1.13 | -1.13 | 3.53 | -0.81 | 702.18 | - |
| Foreign Exchange Rate Adjustments | -1.39 | -1.39 | 14.38 | -4.9 | -1.79 | - |
| Net Cash Flow | -22.02 | -22.02 | -208.31 | 43.96 | 220.67 | -0.13 |
| Free Cash Flow | -177.17 | -177.17 | -111.3 | -89.83 | -63.95 | -66.68 |
| Free Cash Flow Margin | -265.88% | -265.88% | -339.12% | -126.41% | - | - |
| Free Cash Flow Per Share | -0.51 | -0.51 | -0.32 | -0.26 | - | - |
| Cash Interest Paid | 0.06 | 0.06 | 0.07 | - | - | - |
| Cash Income Tax Paid | - | - | - | 1.08 | 1.15 | 0.6 |
| Levered Free Cash Flow | -99.06 | -99.06 | -46.54 | 23.12 | -43.67 | - |
| Unlevered Free Cash Flow | -99.03 | -99.03 | -46.49 | 23.16 | -43.67 | - |
| Change in Net Working Capital | -10.27 | -10.27 | -18.66 | 31.47 | 16.81 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.